STOCK TITAN

111 to Announce Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on March 20, 2025 - Conference Call to Follow

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

111, Inc. (NASDAQ: YI), a tech-enabled healthcare platform company in China, has scheduled the release of its unaudited financial results for Q4 and fiscal year 2024 (ended December 31, 2024) before U.S. market opens on March 20, 2025.

The company will host an earnings conference call at 7:30 AM U.S. Eastern Time (7:30 PM Beijing Time) on the same day. Participants must register in advance through the provided link to receive dial-in details. A live and archived webcast will be available, and a telephone replay will be accessible until March 27, 2025.

111, Inc. (NASDAQ: YI), una società cinese di piattaforme sanitarie abilitate dalla tecnologia, ha programmato il rilascio dei suoi risultati finanziari non auditati per il quarto trimestre e l'anno fiscale 2024 (conclusosi il 31 dicembre 2024) prima dell'apertura del mercato statunitense il 20 marzo 2025.

La società ospiterà una conferenza telefonica sugli utili alle 7:30 AM ora orientale degli Stati Uniti (7:30 PM ora di Pechino) lo stesso giorno. I partecipanti devono registrarsi in anticipo tramite il link fornito per ricevere i dettagli per la chiamata. Sarà disponibile un webcast dal vivo e registrato, e una registrazione telefonica sarà accessibile fino al 27 marzo 2025.

111, Inc. (NASDAQ: YI), una empresa de plataforma de atención médica habilitada por tecnología en China, ha programado la publicación de sus resultados financieros no auditados para el cuarto trimestre y el año fiscal 2024 (que finalizó el 31 de diciembre de 2024) antes de la apertura del mercado estadounidense el 20 de marzo de 2025.

La empresa llevará a cabo una llamada de conferencia sobre ganancias a las 7:30 AM hora del este de EE. UU. (7:30 PM hora de Beijing) el mismo día. Los participantes deben registrarse con anticipación a través del enlace proporcionado para recibir los detalles de la llamada. Habrá un webcast en vivo y grabado, y una repetición telefónica estará disponible hasta el 27 de marzo de 2025.

111, Inc. (NASDAQ: YI), 중국의 기술 기반 의료 플랫폼 회사가 2024년 4분기 및 회계연도(2024년 12월 31일 종료)의 감사받지 않은 재무 결과를 미국 시장 개장 전에 2025년 3월 20일에 발표할 예정입니다.

회사는 같은 날 오전 7시 30분(베이징 시간 오후 7시 30분)에 실적 발표 전화 회의를 개최합니다. 참가자는 제공된 링크를 통해 사전 등록해야 전화 회의 세부 정보를 받을 수 있습니다. 실시간 및 아카이브된 웹캐스트가 제공되며, 전화 재생은 2025년 3월 27일까지 이용 가능합니다.

111, Inc. (NASDAQ: YI), une entreprise de plateforme de santé activée par la technologie en Chine, a prévu de publier ses résultats financiers non audités pour le quatrième trimestre et l'exercice 2024 (qui s'est terminé le 31 décembre 2024) avant l'ouverture du marché américain le 20 mars 2025.

L'entreprise animera une conférence téléphonique sur les résultats à 7h30, heure de l'Est des États-Unis (19h30, heure de Pékin) le même jour. Les participants doivent s'inscrire à l'avance via le lien fourni pour recevoir les détails d'appel. Un webinaire en direct et archivé sera disponible, et une rediffusion téléphonique sera accessible jusqu'au 27 mars 2025.

111, Inc. (NASDAQ: YI), ein technologiegestütztes Gesundheitsplattformunternehmen in China, hat die Veröffentlichung seiner unauditierten Finanzzahlen für das vierte Quartal und das Geschäftsjahr 2024 (das am 31. Dezember 2024 endete) vor der Eröffnung des US-Marktes am 20. März 2025 angesetzt.

Das Unternehmen wird am selben Tag um 7:30 Uhr Eastern Time (19:30 Uhr Pekinger Zeit) eine Telefonkonferenz zu den Ergebnissen abhalten. Teilnehmer müssen sich im Voraus über den bereitgestellten Link registrieren, um die Einwahldaten zu erhalten. Ein Live- und Archiv-Webcast wird verfügbar sein, und eine telefonische Wiederholung ist bis zum 27. März 2025 zugänglich.

Positive
  • None.
Negative
  • None.

SHANGHAI, Feb. 20, 2025 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2024 ended December 31, 2024, before the U.S. market opens on Thursday, March 20, 2025.

111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, March 20, 2025 (7:30 PM Beijing Time on the same day).

Details for the conference call are as follows:

Conference Topic: 111, Inc. Fourth Quarter and Fiscal Year 2024 Earnings Conference Call
Registration Link: https://s1.c-conf.com/diamondpass/10045645-1mt3o7.html

All participants must use the link provided above to complete the online registration process in advance of the conference call. Upon registering, each participant will then be provided with the dial in number, the Passcode, and your unique access PIN. This information will also be emailed to you as a calendar invite.

Please dial in 15 minutes before the call is scheduled to begin. To join the conference, simply dial the number in the calendar invite and enter the passcode followed by your PIN, and you will join the conference instantly.

A live and archived webcast of the conference call will be available on the website at https://edge.media-server.com/mmc/p/29mixmoj.

A telephone replay of the call will be available after the conclusion of the conference call until March 27, 2025.

China: 4001209216
United States: +1-855-883-1031
International: +61-7-3107-6325
Conference ID: 10045645

About 111, Inc.

111, Inc. (NASDAQ: YI) ("111" or the "Company") is a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China. The Company provides consumers with better access to pharmaceutical products and healthcare services directly through its online retail pharmacy, 1 Pharmacy, and indirectly through its offline virtual pharmacy network. The Company also offers online healthcare services through its internet hospital, 1 Clinic, which provides consumers with cost-effective and convenient online consultation, electronic prescription service, and patient management service. In addition, the Company's online platform, 1 Medicine, serves as a one-stop shop for pharmacies to source a vast selection of pharmaceutical products. With the largest virtual pharmacy network in China, 111 enables offline pharmacies to better serve their customers with cloud-based services. 111 also provides an omni-channel drug commercialization platform to its strategic partners, which includes services such as digital marketing, patient education, data analytics, and pricing monitoring.

For more information on 111, please visit: http://ir.111.com.cn/.

Cision View original content:https://www.prnewswire.com/news-releases/111-to-announce-fourth-quarter-and-fiscal-year-2024-unaudited-financial-results-on-march-20-2025---conference-call-to-follow-302381249.html

SOURCE 111, Inc.

FAQ

When will 111 Inc (YI) release its Q4 and FY2024 earnings?

111 Inc (YI) will release its Q4 and fiscal year 2024 earnings before U.S. market opens on Thursday, March 20, 2025.

What time is 111 Inc's (YI) Q4 2024 earnings conference call?

The earnings conference call is scheduled for 7:30 AM U.S. Eastern Time (7:30 PM Beijing Time) on Thursday, March 20, 2025.

How long will 111 Inc's (YI) Q4 2024 earnings call replay be available?

The telephone replay of the earnings call will be available until March 27, 2025.

How can investors join 111 Inc's (YI) Q4 2024 earnings call?

Investors must register in advance through the provided registration link to receive dial-in details, passcode, and a unique access PIN.

111

NASDAQ:YI

YI Rankings

YI Latest News

YI Stock Data

70.24M
6.97M
16.16%
23.9%
0.04%
Medical Distribution
Healthcare
Link
China
Shanghai